According to WHO, currently, more than 55 million people live with dementia worldwide, and there are nearly 10 million new cases every year. The most common type (60-70%) of dementia is Alzheimer’s disease (AD), a progressive disease characterized by memory loss, language breakdown, and eventually, death. The main pathological factor for AD is thought to be the progressive accumulation of amyloid beta (Aβ) peptides in the brain, generated by the cleavage of the amyloid precursor protein (APP) by a combination of β-secretases and γ-secretases. Hyperphosphorylation of tau, a microtubule-associated protein which aggregates to form tangles, also damages the brains of patients with AD. This year, we’re excited to announce that ANKASCIN® 568 product has successfully received a health certificate for “Anti-aging” Support. SunWay research demonstrates the protective effect of ANKASCIN® 568 in 4 aging models: Amyloid β-Infused Rats In this study, the effects of dietary administration of ANKASCIN® 568 on memory and learning abilities are confirmed in an animal model of AD rats infused with Aβ40 into the cerebral ventricle. During continuous Aβ40 infusion for 28 days, ANKASCIN® 568 administration potently reverses the memory deficit in the memory task. Aβ40 infusion increases acetylcholinesterase activity, reactive oxygen species, and lipid peroxidation and decreases total antioxidant status and superoxide dismutase activity in brain, but these damages were potently reversed by ANKASCIN® 568 administration. The protection provided […]

  “The superior effects of MS and AK in ANKASCIN® 568-R show significant results, from managing glycation and inflammation to improving hyperglycemia, hyperlipidemia, hypertension, and cognitive health. This novel ingredient is clinically proven, safe, has multiple applications in dietary supplements and functional food, is compliant with EU and US regulations, and provides excellent support for healthy aging.”   According to the WHO, around one in ten people in Europe or US has diabetes, which means that if you go out with your relatives, there’s a good chance that the person you’re arm-in-arm with is someone who has diabetes. Chronic diabetic complications, including hyperlipidemia, hypertension, or Alzheimer’s disease, have been related to advanced glycation end product (AGE) accumulation. Glycation and AGEs lead to accelerated organ aging, thus causing the vicious cycle of tissue glycation and aging. However, the Western diet, which is full of AGEs, and COVID-19 have aggravated this already grim scenario. Reports show that patients with hyperglycemia and COVID-19 have a 2-to-4-fold risk of severe COVID-19 or death than those without diabetes. ANKASCIN® 568-R is a state-of-the-art ingredient containing high MS and AK levels. It addresses the root cause, mainly via PPARγ/Nrf2 pathways, to manage anti-glycation, antioxidant, and anti-inflammation and acts synergistically in improving the impairment of pancreatic β-cell function (blood glucose regulation), resolving lipid plaque accumulation in the blood […]

Under the leadership of Chairman Dr. George Lee and President John Pan, SunWay Biotech won the 14th in the 2020 TOP 5000 large-scale enterprise ranking in the biotechnology service industry!